KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:可得 入排置信度 0.98

Clinical evaluation of the efficacy and safety of nasturtium herb and horseradish root versus placebo in the continuous prophylaxis of recurrent uncomplicated cystitis: a double-blind randomised clinical trial.

Uwe Albrecht, Gregor Schmitz, Ulrich Stefenelli, Nina Kassner, Meinolf Wonnemann, Lukas Schablauer, Niklas Lonnemann, Lisa Felix, Ruth Kirschner-Hermanns

BMC Complement Med Ther 26(1) 127

PMID41782129
PMCIDPMC13063873
DOI10.1186/s12906-026-05328-z
发表日期2026-03-04
入排依据:未发现恶性肿瘤人群证据。
疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 已检查 3 张 PMC Figure,均未识别为 KM 图:Fig. 1:CONSORT/入组流程图;Fig. 2:ROC 图;Fig. 3:非 KM 图。
摘要

摘要

BACKGROUND AND OBJECTIVES: This study aimed to demonstrate the efficacy and safety of a herbal combination drug of nasturtium herb and horseradish root in the continuous prophylaxis of recurring uncomplicated cystitis. METHODS: The clinical trial was conducted as a phase III, two-armed, placebo-controlled, randomised, double-blind, prospective, and multi-center study, which followed a parallel-group design in Germany. Data were collected in a multicenter setup in Germany. Patients of either sex aged ≥ 18 years with recurring uncomplicated cystitis were considered for the study. Interventions were Nasturtium herb and horseradish root prophylaxis versus placebo. The primary outcome measure was the rate of first recurrent urinary tract infection (rUTI) observed during six months of recurrence prophylaxis in the herbal and the placebo group from day 0 to day 180. Additional efficacy outcome measures included: recurrence rates at scheduled visits during the course of recurrence prophylaxis; recurrence rates during three- and six-month follow-up and Investigator’s assessment of efficacy at completion of recurrence prophylaxis. Safety evaluation included type, frequency, and severity of reported adverse events. RESULTS: A total of 224 patients were enrolled, of which 217 women were included in the full analysis set. Patients were randomised to treatment with either nasturtium herb and horseradish root (N = 110) or placebo (N = 107). The cumulative recurrence rate increased for the placebo group to approximately 40% by day 90 and 48% by day 180, while the nasturtium herb and horseradish root group had lower rates of 26% and 36%, respectively. The overall risk of rUTI was reduced by 36% (hazard ratio [HR] 0.64, 95% confidence interval [CI] 0.42–0.97, p = 0.0327) in the treatment group. This effect remained consistent (although statistically insignificant) during the follow-up period up to 360 days. There were no significant differences between groups, for any of the reported adverse effects. CONCLUSION: The results of this study indicate that nasturtium herb and horseradish root may be an effective, safe prophylactic treatment for female patients suffering from rUTIs. TRIAL REGISTRATION: This trial was registered with EudraCT under the number: EudraCT 2013-004653-25. The study was approved on 2nd of May 2014 and the first participant was enrolled on 9th of May 2014.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。
其他 Figure(3,默认折叠)

这些图片未产生 KM 曲线结果,不在主页面重复展示。

Fig. 1Flow diagram of patient numbers. Some patients were excluded from the PP set for more than one reason
非 KM Figure
Fig. 2Schematic overview of the study procedure. Patient inclusion after signing the informed consent at visit 1
非 KM Figure
Fig. 3Cumulative recurrence rate of urinary tract infections (± 95%CI) in FAS of female patients receiving nasturtium herb and horseradish root (red; N = 110) and placebo (blue; N = 107) treatments over the 180 days treatment period. Analysis was performed by log-rank test at an unadjusted α = 0.05. All statistics are descriptive
非 KM Figure